National Covaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 Months BY Outlook News Desk
National Australia Recognises Covaxin: All Countries That Have Approved Bharat Biotech's Covid-19 Vaccine BY Outlook News Desk
National Covaxin: 7 Countries Allowing Entry To Indians Vaccinated With Bharat Biotech's Covid-19 Shot BY Outlook News Desk
Making A Difference Covid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel Rules BY Outlook News Desk
National 100 Crore Shots: How India Achieved Covid-19 Vaccination Milestone In 280 Days BY Outlook News Desk
National WHO Technical Group To Meet On Oct 26 To Consider EUL Of Bharat Biotech’s Covaxin BY Outlook News Desk
National Covid Expert Panel Approves Bharat Biotech's Covaxin For Children Between 2-18 BY Outlook News Desk
National Bharat Biotech's New Plant Dispatches First Commercial Batch Of Covaxin BY Outlook News Desk
National Over 3.86 Crore People Yet To Get Complete Vaccination Within Stipulated Time: Govt BY Outlook News Desk
National Mixing Covaxin and Covishield: India's Drug Authority Gives Nod To Study, Trials BY Outlook News Desk
National Combination Of Covishield, Covaxin Better Than 2 Doses Of Same Vaccine: ICMR Study BY Outlook Web Bureau
National Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister BY Outlook News Desk
National Covaxin Provides Protection Against Delta Plus Covid Variant: ICMR Study BY Outlook Web Bureau
National Covid-19: Delhi Govt Reserves 40% Covaxin Stock And 20% Covishield Jabs For 1st Shot BY Outlook Web Bureau
Making A Difference Brazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa Medicamentos BY Outlook Web Bureau
National Health Ministry Aware Of 'Some' Controversy Around Covaxin Supply To Brazil: Govt In Lok Sabha BY Outlook Web Bureau
National Bharat Biotech To Supply 500 Million Covaxin Doses To Centre for Immunisation Programme BY Outlook News Desk
National Father-Daughter Duo Who Risked Life For Vaccine Trial Begs For Jabs For Kin BY Jeevan Prakash Sharma
National Submitted Documents To WHO For Covaxin’s Emergency Use Listing: Bharat Biotech BY Outlook Web Bureau
